Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B5315 PLP (139-151)Summary: Synthetic myelin proteolipid protein (PLP) fragment -
B5433 Prion Protein 106-126 (human) TFASummary: Prion peptide fragment that exhibits neurotoxicity -
B5602 GGsTopSummary: γ-glutamyl transpeptidase (GGT) inhibitor, novel and irreversible -
B5619 1-DeazaadenosineSummary: adenosine deaminase inhibitor -
B5660 SB 747651A dihydrochlorideSummary: mitogen- and stress-activated kinase 1 (MSK1) inhibitor -
B5716 GalloflavinSummary: human lactate dehydrogenase (LDH) inhibitor -
B5723 MethoxyresorufinSummary: fluorometric substrate of cytochrome P450 -
B5724 PentoxyresorufinSummary: fluorometric cytochrome P450 substrate -
B5785 Cystamine dihydrochlorideSummary: transglutaminase inhibitor -
N1705 IcariinSummary: PDE5 inhibitor
